Biotech

All Articles

Arch shuts $3B-plus fund to foster biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Capital Life Sciences, Arch Venture Allies is ac...

Orion to use Aitia's 'electronic twins' to locate new cancer medications

.Finnish biotech Orion has actually snooped prospective in Aitia's "electronic double" specialist to...

Windtree's surprise med raises blood pressure in most up-to-date period 2 succeed

.While Windtree Therapies has struggled to develop the economic roots required to make it through, a...

2 cancer cells biotechs combine, creating global footprint

.OncoC4 is actually taking AcroImmune-- as well as its internal scientific manufacturing abilities--...

Amgen reports first stage 3 gain for $400M dermatitis medicine

.Amgen has discussed (PDF) the initial period 3 records on its own $400 million dermatitis medicatio...

Biogen, UCB file period 3 lupus succeed after failing earlier test

.Biogen and UCB's depend developing into stage 3 on the back of an unsuccessful research study wants...

Aptadir wishes brand-new RNA preventions may reverse tricky cancers cells

.Italian biotech Aptadir Rehabs has launched along with the pledge that its own pipe of preclinical ...

Wave surfs DMD success to regulatory authorities' doors, sending out stock up

.Surge Lifestyle Sciences has met its own target in a Duchenne muscle dystrophy (DMD) research, inst...

Sanofi picks brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma crea...

Achilles drops cell treatment system, prepares for discharges after missing out on 'commercial stability' objectives

.Achilles Therapeutics has destroyed its approach. The English biotech is knocking off on its own cl...